Basic Information | Post buying leads | Suppliers |
Name |
Oxythiamine |
EINECS | N/A |
CAS No. | 136-16-3 | Density | g/cm3 |
PSA | 98.36000 | LogP | -1.46290 |
Solubility | N/A | Melting Point |
N/A |
Formula | C12H16 N3 O2 S | Boiling Point | °Cat760mmHg |
Molecular Weight | 266.37 | Flash Point | °C |
Transport Information | N/A | Appearance | N/A |
Safety | Moderately toxic by subcutaneous route. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and SOx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Thiazolium,3-[(1,4-dihydro-2-methyl-4-oxo-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-(9CI); Thiazolium,5-(2-hydroxyethyl)-3-[(4-hydroxy-2-methyl-5-pyrimidinyl)methyl]-4-methyl-(8CI); 4'-Oxythiamin; Hydroxythiamin; Oxythiamin; Oxythiamine |
Chemistry informtion about Oxythiamine (CAS NO.136-16-3) is:
IUPAC Name: 5-[[5-(2-Hydroxyethyl)-4-Methyl-1,3-Thiazol-3-Ium-3-Yl]Methyl]-2-Methyl-1H-Pyrimidin-6-One Chloride
Synonyms: Thiazolium,5-(2-Hydroxyethyl)-3-((4-Hydroxy-2-Methyl-5-Pyrimidinyl)Methyl)-4-M ; 5-(2-Hydroxyethyl)-3-(4-Hydroxy-2-Methyl-5-Pyrimidinylmethyl)-4-Methylthiazolium Chloride ; 5-[2-Hydroxyethyl]-3-[4-Hydroxy-2-Methyl-5-Pyrimidinylmethyl]-4-Methylthiazolium Chloride Hydrochloride ; Oxythiamine Chloride Hydrochloride ; Oxythiamine Hcl ; Oxythiamine Hydrochloride ; 5-(2-Hydroxyethyl)-3-((4-Hydroxy-2-Methyl-5-Pyrimidinyl)Methyl)-4-Methyl-Thi ; Azolium
MF: C12H17Cl2N3O2S
MW: 338.25
Storage temp.: −20°C
Following is the molecular structure of Oxythiamine (CAS NO.136-16-3) is:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | subcutaneous | 1430mg/kg (1430mg/kg) | Pharmaceutical Chemistry Journal Vol. 16, Pg. 848, 1982. |
Moderately toxic by subcutaneous route. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and SOx.
Oxythiamine (CAS NO.136-16-3) differs from thiamine in having the amino group in the pyrimidine ring replaced by a hydroxyl group and that is a thiamine antagonist producing symptoms of thiamine deficiency.